| 1.9 |
5.6 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.6 |
2.3 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.5 |
1.6 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.4 |
1.1 |
GO:0042495 |
detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.3 |
1.0 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.3 |
6.4 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.3 |
1.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.7 |
GO:1905072 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.2 |
1.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 |
3.8 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.2 |
2.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
0.7 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
1.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.2 |
0.6 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 |
0.6 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.2 |
0.7 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
0.7 |
GO:0009804 |
coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
| 0.2 |
2.6 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
0.5 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.2 |
0.5 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 |
0.3 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.1 |
0.1 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.1 |
0.9 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.1 |
1.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.6 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.4 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
2.5 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.1 |
1.6 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 |
1.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.5 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.1 |
0.4 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.2 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.1 |
0.5 |
GO:0001970 |
positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.1 |
0.6 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
1.0 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.8 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.4 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
3.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.4 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.4 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.0 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.1 |
1.0 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.1 |
0.3 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.6 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.5 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
4.7 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.5 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
0.7 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.2 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.1 |
0.8 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
1.2 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
2.4 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
1.3 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.1 |
6.0 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.2 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 |
0.7 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.2 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.7 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.2 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.2 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.1 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
0.4 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.1 |
0.4 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.7 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.1 |
0.2 |
GO:1900111 |
regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 |
0.2 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.6 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.4 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.5 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.2 |
GO:0052314 |
isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.1 |
0.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.7 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.4 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.6 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.1 |
0.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
2.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.2 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
1.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.1 |
0.4 |
GO:0097068 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 |
0.2 |
GO:1904798 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
1.4 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.1 |
1.9 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
0.1 |
GO:2000547 |
regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.1 |
0.2 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
0.1 |
GO:1902567 |
negative regulation of eosinophil activation(GO:1902567) |
| 0.1 |
0.4 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.1 |
0.8 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.2 |
GO:0019566 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 |
0.1 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.1 |
0.2 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
5.4 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.2 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.4 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.2 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.1 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.0 |
0.1 |
GO:0099543 |
retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.0 |
0.0 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.0 |
0.4 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.0 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.0 |
0.4 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.5 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.2 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.0 |
0.1 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.1 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.6 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.2 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.1 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) inner medullary collecting duct development(GO:0072061) |
| 0.0 |
7.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0070428 |
negative regulation of interleukin-23 production(GO:0032707) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.0 |
0.2 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.3 |
GO:2000197 |
regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.2 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.0 |
0.1 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.2 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.1 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.1 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.0 |
0.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.0 |
0.3 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 |
0.3 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.0 |
0.4 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.0 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.2 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.0 |
0.1 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.0 |
0.2 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.0 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.0 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.0 |
0.4 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.7 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.1 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 |
0.2 |
GO:0030202 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.0 |
0.6 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.0 |
0.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:1900133 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:1903674 |
regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.0 |
0.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.5 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.0 |
0.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.1 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.0 |
0.1 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 |
0.2 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.6 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.0 |
0.1 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.6 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.0 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
2.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.0 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.0 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
0.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.0 |
0.4 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) 'de novo' NAD biosynthetic process(GO:0034627) |
| 0.0 |
0.3 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.0 |
0.5 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
1.4 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
1.3 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.5 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 |
0.1 |
GO:0071222 |
cellular response to biotic stimulus(GO:0071216) cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
| 0.0 |
0.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0001812 |
positive regulation of type I hypersensitivity(GO:0001812) |
| 0.0 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.2 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 |
0.3 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.1 |
GO:0060748 |
paracrine signaling(GO:0038001) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 |
0.4 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
3.3 |
GO:0007586 |
digestion(GO:0007586) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.3 |
GO:0060307 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.0 |
0.1 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.0 |
0.2 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.4 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.1 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 |
0.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.2 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.3 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.6 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.3 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.0 |
0.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.1 |
GO:0046606 |
negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.5 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.0 |
0.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.1 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.0 |
0.0 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.1 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.0 |
0.3 |
GO:0015866 |
ADP transport(GO:0015866) ATP transport(GO:0015867) |
| 0.0 |
0.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.0 |
0.1 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.2 |
GO:0032196 |
transposition(GO:0032196) |
| 0.0 |
0.2 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.1 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.0 |
0.0 |
GO:0010841 |
positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 0.0 |
0.1 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.2 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.0 |
0.3 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
0.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.4 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 |
0.0 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.0 |
0.3 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 |
0.9 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:2000741 |
asymmetric neuroblast division(GO:0055059) regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.2 |
GO:0010976 |
positive regulation of neuron projection development(GO:0010976) |
| 0.0 |
0.3 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.2 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
1.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.0 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.2 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:0036343 |
third ventricle development(GO:0021678) psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.0 |
0.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.1 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.0 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
0.2 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 |
0.1 |
GO:0072218 |
ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
| 0.0 |
0.2 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 |
0.0 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.2 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.0 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 |
0.0 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.6 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.1 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.0 |
0.2 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.1 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.0 |
0.0 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.1 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.2 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.3 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 0.0 |
0.7 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
0.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.2 |
GO:0002517 |
T cell tolerance induction(GO:0002517) |
| 0.0 |
0.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.3 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.2 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.0 |
0.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.5 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.1 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.4 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
